The cell culture market in Norway is expected to reach a projected revenue of US$ 391.9 million by 2033. A compound annual growth rate of 11% is expected of Norway cell culture market from 2026 to 2033.
In terms of revenue, Norway accounted for 0.9% of the global cell culture market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, UK cell culture market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 3,147.7 million by 2033.
Norway has an advanced biotechnology industry, a favorable investment climate, supportive policies, and incentives for biotechnology & biopharmaceutical companies. The key players, such as Thermo Fisher Scientific, Eppendorf, and Merck KGaA, are present locally.
In addition, Norway’s well-developed infrastructure, including advanced laboratories, manufacturing facilities, and quality control systems, supports the life sciences industry. Furthermore, the presence of established scientific institutions & emerging innovators in the cell and gene therapy space is expected to support market growth over the forecast period.
For instance, in June 2020, Norway-based Zelluna Immunotherapy, a company specializing in T Cell Receptor (TCR) cell therapy, successfully concluded its fundraising efforts for advancing the development of its unique TCR-NK cell therapy platform for the treatment of various cancer types. These factors are indicative of the growth potential of the country in the biotechnology industry and can positively affect the cell culture market.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Culture Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.54% in 2025.
Horizon Databook has segmented the Norway cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
Norway has an advanced biotechnology industry, a favorable investment climate, supportive policies, and incentives for biotechnology & biopharmaceutical companies. The key players, such as Thermo Fisher Scientific, Eppendorf, and Merck KGaA, are present locally.
In addition, Norway’s well-developed infrastructure, including advanced laboratories, manufacturing facilities, and quality control systems, supports the life sciences industry. Furthermore, the presence of established scientific institutions & emerging innovators in the cell and gene therapy space is expected to support market growth over the forecast period.
For instance, in June 2020, Norway-based Zelluna Immunotherapy, a company specializing in T Cell Receptor (TCR) cell therapy, successfully concluded its fundraising efforts for advancing the development of its unique TCR-NK cell therapy platform for the treatment of various cancer types. These factors are indicative of the growth potential of the country in the biotechnology industry and can positively affect the cell culture market.
Norway Cell Culture Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
Norway Cell Culture Market Application Outlook (Revenue, USD Million , 2021-2033)
Biopharmaceutical Production
Drug Development
Diagnostics
Tissue Culture & Engineering
Cell and Gene Therapy
Toxicity Testing
Other Applications
Reasons to subscribe to Cell Culture Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cell Culture Market Outlook databook
Our clientele includes a mix of Cell Culture Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway Cell Culture Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Norway Cell Culture Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.